BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Merani S, Pawelec G, Kuchel GA, McElhaney JE. Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection. Front Immunol 2017;8:784. [PMID: 28769922 DOI: 10.3389/fimmu.2017.00784] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 Riese P, Trittel S, Akmatov MK, May M, Prokein J, Illig T, Schindler C, Sawitzki B, Elfaki Y, Floess S, Huehn J, Błażejewski AJ, Strowig T, Hernandez-vargas EA, Geffers R, Zhang B, Li Y, Pessler F, Guzmán CA. Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly. Nat Commun 2022;13:6894. [DOI: 10.1038/s41467-022-34487-z] [Reference Citation Analysis]
2 Ferreira IA, Lee CY, Foster W, Abdullahi A, Tuong ZK, Stewart BJ, Ferdinand JR, Guillaume S, Potts MO, Perera M, Krishna BA, Alonso AP, Cabantous M, Kemp SA, Ceron-gutierrez L, Ebrahimi S, Lyons P, Smith KG, Bradley J, Collier DA, Teichmann SA, Mccoy LE, Macary PA, Doffinger R, Wills MR, Linterman M, Clatworthy MR, Gupta RK, The CITIID-NIHR BioResource COVID-19 Collaboration. Atypical B cells and impaired SARS-CoV-2 neutralisation following booster vaccination in the elderly.. [DOI: 10.1101/2022.10.13.22281024] [Reference Citation Analysis]
3 Kumar M, James MM, Kumawat M, Nabi B, Sharma P, Pal N, Shubham S, Tiwari RR, Sarma DK, Nagpal R. Aging and Microbiome in the Modulation of Vaccine Efficacy. Biomedicines 2022;10:1545. [DOI: 10.3390/biomedicines10071545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Breznik JA, Huynh A, Zhang A, Bilaver L, Bhakta H, Stacey HD, Ang JC, Bramson JL, Nazy I, Miller MS, Denburg J, Costa AP, Bowdish DME, other members of the COVID-in-LTC Investigator Group. CMV seropositivity in older adults changes the T cell repertoire, but does not prevent antibody or cellular responses to SARS-CoV-2 vaccination.. [DOI: 10.1101/2022.05.27.22275673] [Reference Citation Analysis]
5 Weber S, Kehl V, Erber J, Wagner KI, Jetzlsperger AM, Burrell T, Schober K, Schommers P, Augustin M, Crowell CS, Gerhard M, Winter C, Moosmann A, Spinner CD, Protzer U, Hoffmann D, D'Ippolito E, Busch DH. CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients. PLoS One 2022;17:e0268530. [PMID: 35613127 DOI: 10.1371/journal.pone.0268530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Alcendor DJ, Matthews-juarez P, Smoot D, Hildreth JEK, Lamar K, Tabatabai M, Wilus D, Juarez PD. Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic. Vaccines 2022;10:755. [DOI: 10.3390/vaccines10050755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Salminen A. Clinical perspectives on the age-related increase of immunosuppressive activity. J Mol Med (Berl) 2022. [PMID: 35384505 DOI: 10.1007/s00109-022-02193-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bell MR, Kutzler MA. An old problem with new solutions: Strategies to improve vaccine efficacy in the elderly. Adv Drug Deliv Rev 2022;183:114175. [PMID: 35202770 DOI: 10.1016/j.addr.2022.114175] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Brumme ZL, Mwimanzi F, Lapointe HR, Cheung PK, Sang Y, Duncan MC, Yaseen F, Agafitei O, Ennis S, Ng K, Basra S, Lim LY, Kalikawe R, Speckmaier S, Moran-garcia N, Young L, Ali H, Ganase B, Umviligihozo G, Harrison Omondi F, Atkinson K, Sudderuddin H, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes D, Demarco ML, Simons J, Hedgcock M, Romney MG, Barrios R, Guillemi S, Brumme CJ, Pantophlet R, Montaner JSG, Niikura M, Harris M, Hull M, Brockman MA. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy. npj Vaccines 2022;7. [DOI: 10.1038/s41541-022-00452-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
10 Moysi E, Paris RM, Le Grand R, Koup RA, Petrovas C. Human lymph node immune dynamics as driver of vaccine efficacy: an understudied aspect of immune responses. Expert Rev Vaccines 2022. [PMID: 35193447 DOI: 10.1080/14760584.2022.2045198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Teissier T, Boulanger E, Cox LS. Interconnections between Inflammageing and Immunosenescence during Ageing. Cells 2022;11:359. [DOI: 10.3390/cells11030359] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
12 Felismino ES, Santos JMB, Rossi M, Santos CAF, Durigon EL, Oliveira DBL, Thomazelli LM, Monteiro FR, Sperandio A, Apostólico JS, França CN, Amaral JB, Amirato GR, Vieira RP, Vaisberg M, Bachi ALL. Better Response to Influenza Virus Vaccination in Physically Trained Older Adults Is Associated With Reductions of Cytomegalovirus-Specific Immunoglobulins as Well as Improvements in the Inflammatory and CD8+ T-Cell Profiles. Front Immunol 2021;12:713763. [PMID: 34712226 DOI: 10.3389/fimmu.2021.713763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kvistad D, Pallikkuth S, Sirupangi T, Pahwa R, Kizhner A, Petrovas C, Villinger F, Pahwa S. IL-21 enhances influenza vaccine responses in aged macaques with suppressed SIV infection. JCI Insight 2021;6:e150888. [PMID: 34491910 DOI: 10.1172/jci.insight.150888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Brumme ZL, Mwimanzi F, Lapointe HR, Cheung P, Sang Y, Duncan MC, Yaseen F, Agafitei O, Ennis S, Ng K, Basra S, Lim LY, Kalikawe R, Speckmaier S, Moran-Garcia N, Young L, Ali H, Ganase B, Umviligihozo G, Omondi FH, Atkinson K, Sudderuddin H, Toy J, Sereda P, Burns L, Costiniuk CT, Cooper C, Anis AH, Leung V, Holmes D, DeMarco ML, Simons J, Hedgcock M, Romney MG, Barrios R, Guillemi S, Brumme CJ, Pantophlet R, Montaner JSG, Niikura M, Harris M, Hull M, Brockman MA. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy. medRxiv 2021:2021. [PMID: 34671779 DOI: 10.1101/2021.10.03.21264320] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Vivek S, Nelson HH, Prizment AE, Faul J, Crimmins EM, Thyagarajan B. Cross sectional association between cytomegalovirus seropositivity, inflammation and cognitive impairment in elderly cancer survivors. Cancer Causes Control 2021. [PMID: 34637066 DOI: 10.1007/s10552-021-01504-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Brockman MA, Mwimanzi F, Lapointe HR, Sang Y, Agafitei O, Cheung P, Ennis S, Ng K, Basra S, Lim LY, Yaseen F, Young L, Umviligihozo G, Omondi FH, Kalikawe R, Burns L, Brumme CJ, Leung V, Montaner JS, Holmes D, Demarco M, Simons J, Pantophlet R, Niikura M, Romney MG, Brumme ZL. Reduced magnitude and durability of humoral immune responses by COVID-19 mRNA vaccines among older adults.. [DOI: 10.1101/2021.09.06.21263149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Baroncelli S, Galluzzo CM, Liotta G, Andreotti M, Orlando S, Ciccacci F, Mphwere R, Luhanga R, Sagno JB, Amici R, Marazzi MC, Giuliano M. HIV-exposed infants with EBV infection have a reduced persistence of the immune response to the HBV vaccine. AIDS Res Ther 2021;18:48. [PMID: 34348748 DOI: 10.1186/s12981-021-00375-7] [Reference Citation Analysis]
18 Collier DA, Ferreira IATM, Kotagiri P, Datir RP, Lim EY, Touizer E, Meng B, Abdullahi A, Elmer A, Kingston N, Graves B, Le Gresley E, Caputo D, Bergamaschi L, Smith KGC, Bradley JR, Ceron-Gutierrez L, Cortes-Acevedo P, Barcenas-Morales G, Linterman MA, McCoy LE, Davis C, Thomson E, Lyons PA, McKinney E, Doffinger R, Wills M, Gupta RK; CITIID-NIHR BioResource COVID-19 Collaboration. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature 2021;596:417-22. [PMID: 34192737 DOI: 10.1038/s41586-021-03739-1] [Cited by in Crossref: 286] [Cited by in F6Publishing: 314] [Article Influence: 286.0] [Reference Citation Analysis]
19 Mccarthy EE, Odorizzi PM, Lutz E, Smullin CP, Tenvooren I, Stone M, Simmons G, Hunt PW, Feeney ME, Norris PJ, Busch MP, Spitzer MH, Rutishauser RL. Distinct cellular immune signatures in acute Zika virus infection are associated with high or low persisting neutralizing antibody titers.. [DOI: 10.1101/2021.05.27.446054] [Reference Citation Analysis]
20 Higdon LE, Gustafson CE, Ji X, Sahoo MK, Pinsky BA, Margulies KB, Maecker HT, Goronzy J, Maltzman JS. Association of Premature Immune Aging and Cytomegalovirus After Solid Organ Transplant. Front Immunol 2021;12:661551. [PMID: 34122420 DOI: 10.3389/fimmu.2021.661551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Verschoor CP, Haynes L, Pawelec G, Loeb M, Andrew MK, Kuchel GA, Mcelhaney JE. Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults. Front Aging 2021;2. [DOI: 10.3389/fragi.2021.649110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 van den Berg SPH, Lanfermeijer J, Jacobi RHJ, Hendriks M, Vos M, van Schuijlenburg R, Nanlohy NM, Borghans JAM, van Beek J, van Baarle D, de Wit J. Latent CMV Infection Is Associated With Lower Influenza Virus-Specific Memory T-Cell Frequencies, but Not With an Impaired T-Cell Response to Acute Influenza Virus Infection. Front Immunol 2021;12:663664. [PMID: 34025665 DOI: 10.3389/fimmu.2021.663664] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
23 Brockman MA, Mwimanzi F, Sang Y, Ng K, Agafitei O, Ennis S, Lapointe H, Young L, Umviligihozo G, Burns L, Brumme C, Leung V, Montaner JSG, Holmes D, DeMarco M, Simons J, Niikura M, Pantophlet R, Romney MG, Brumme ZL. Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine. medRxiv 2021:2021. [PMID: 33791737 DOI: 10.1101/2021.03.17.21253773] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
24 Tylutka A, Morawin B, Gramacki A, Zembron-Lacny A. Lifestyle exercise attenuates immunosenescence; flow cytometry analysis. BMC Geriatr 2021;21:200. [PMID: 33752623 DOI: 10.1186/s12877-021-02128-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
25 Söderberg-Nauclér C. Does reactivation of cytomegalovirus contribute to severe COVID-19 disease? Immun Ageing 2021;18:12. [PMID: 33712035 DOI: 10.1186/s12979-021-00218-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
26 Connors J, Bell MR, Marcy J, Kutzler M, Haddad EK. The impact of immuno-aging on SARS-CoV-2 vaccine development. Geroscience 2021;43:31-51. [PMID: 33569701 DOI: 10.1007/s11357-021-00323-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 18.0] [Reference Citation Analysis]
27 Collier DA, Ferreira IA, Kotagiri P, Datir R, Lim E, Touzier E, Meng B, Abdullahi A, Elmer A, Kingston N, Graves B, Gresley EL, Caputo D, Smith KG, Bradley JR, Ceron-gutierrez L, Cortes-acevedo P, Barcenas-morales G, Linterman M, Mccoy L, Davis C, Thomson E, Lyons PA, Mckinney E, Doffinger R, Wills M, Gupta RK, The CITIID-NIHR BioResource COVID-19 Collaboration. Age-related heterogeneity in immune responses to SARS-CoV-2 vaccine BNT162b2.. [DOI: 10.1101/2021.02.03.21251054] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 19.0] [Reference Citation Analysis]
28 Connors J, Haddad EK, Petrovas C. Aging alters immune responses to vaccines. Aging (Albany NY) 2021;13:1568-70. [PMID: 33510048 DOI: 10.18632/aging.202598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Mcelhaney JE, Frasca D. Influenza Vaccination in Older Adults. Encyclopedia of Gerontology and Population Aging 2021. [DOI: 10.1007/978-3-030-22009-9_69] [Reference Citation Analysis]
30 Caruso C, Aiello A, Pawelec G, Ligotti ME. Vaccination in old age: Challenges and promises. Human Aging 2021. [DOI: 10.1016/b978-0-12-822569-1.00020-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Clark BL, Thomas PG. A Cell for the Ages: Human γδ T Cells across the Lifespan. Int J Mol Sci 2020;21:E8903. [PMID: 33255339 DOI: 10.3390/ijms21238903] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
32 Batista MA, Calvo-Fortes F, Silveira-Nunes G, Camatta GC, Speziali E, Turroni S, Teixeira-Carvalho A, Martins-Filho OA, Neretti N, Maioli TU, Santos RR, Brigidi P, Franceschi C, Faria AMC. Inflammaging in Endemic Areas for Infectious Diseases. Front Immunol 2020;11:579972. [PMID: 33262758 DOI: 10.3389/fimmu.2020.579972] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
33 Bischof N, Wehmeier C, Dickenmann M, Hirt-Minkowski P, Amico P, Steiger J, Naegele K, Hirsch HH, Schaub S. Revisiting cytomegalovirus serostatus and replication as risk factors for inferior long-term outcomes in the current era of renal transplantation. Nephrol Dial Transplant 2020;35:346-56. [PMID: 31943075 DOI: 10.1093/ndt/gfz268] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
34 Kinsella S, Evandy CA, Cooper K, Iovino L, deRoos PC, Hopwo KS, Granadier DW, Smith CW, Rafii S, Dudakov JA. Attenuation of homeostatic signaling from apoptotic thymocytes triggers a global regenerative response in the thymus.. [DOI: 10.1101/2020.08.31.275834] [Reference Citation Analysis]
35 Rozhnova G, E Kretzschmar M, van der Klis F, van Baarle D, Korndewal M, C Vossen A, van Boven M. Short- and long-term impact of vaccination against cytomegalovirus: a modeling study. BMC Med 2020;18:174. [PMID: 32611419 DOI: 10.1186/s12916-020-01629-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
36 Loeb N, Andrew MK, Loeb M, Kuchel GA, Haynes L, McElhaney JE, Verschoor CP. Frailty Is Associated With Increased Hemagglutination-Inhibition Titers in a 4-Year Randomized Trial Comparing Standard- and High-Dose Influenza Vaccination. Open Forum Infect Dis 2020;7:ofaa148. [PMID: 32500087 DOI: 10.1093/ofid/ofaa148] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
37 De Sanctis JB. Pharmacologic Modulation of the Immune Response Against Tumours in the Elderly. Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models 2020. [DOI: 10.1007/978-981-15-7586-0_8] [Reference Citation Analysis]
38 Kostadinova L, Shive CL, Anthony DD. Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation. Cancers (Basel) 2019;11:E1867. [PMID: 31769428 DOI: 10.3390/cancers11121867] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
39 Dhakal S, Klein SL. Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs. J Virol 2019;93:e00797-19. [PMID: 31391269 DOI: 10.1128/JVI.00797-19] [Cited by in Crossref: 47] [Cited by in F6Publishing: 1] [Article Influence: 15.7] [Reference Citation Analysis]
40 Dhakal S, Klein SL. Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs. J Virol 2019;93:e00797-19. [PMID: 31391269 DOI: 10.1128/JVI.00797-19] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 18.7] [Reference Citation Analysis]
41 Coll PP, Costello VW, Kuchel GA, Bartley J, McElhaney JE. The Prevention of Infections in Older Adults: Vaccination. J Am Geriatr Soc 2020;68:207-14. [PMID: 31613000 DOI: 10.1111/jgs.16205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
42 Herrero-Fernández I, Rosado-Sánchez I, Álvarez-Ríos AI, Galvá MI, De Luna-Romero M, Sanbonmatsu-Gámez S, Pérez-Ruiz M, Navarro-Marí JM, Carrillo-Vico A, Sánchez B, Ramos R, Cañizares J, Leal M, Pacheco YM. Effect of homeostatic T-cell proliferation in the vaccine responsiveness against influenza in elderly people. Immun Ageing 2019;16:14. [PMID: 31312227 DOI: 10.1186/s12979-019-0154-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
43 Pallikkuth S, de Armas LR, Rinaldi S, George VK, Pan L, Arheart KL, Pahwa R, Pahwa S. Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study. PLoS Biol 2019;17:e3000257. [PMID: 31100059 DOI: 10.1371/journal.pbio.3000257] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
44 Moss P. 'From immunosenescence to immune modulation': a re-appraisal of the role of cytomegalovirus as major regulator of human immune function. Med Microbiol Immunol 2019;208:271-80. [PMID: 31053999 DOI: 10.1007/s00430-019-00612-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
45 Ciabattini A, Nardini C, Santoro F, Garagnani P, Franceschi C, Medaglini D. Vaccination in the elderly: The challenge of immune changes with aging. Semin Immunol 2018;40:83-94. [PMID: 30501873 DOI: 10.1016/j.smim.2018.10.010] [Cited by in Crossref: 177] [Cited by in F6Publishing: 186] [Article Influence: 59.0] [Reference Citation Analysis]
46 van den Berg SPH, Warmink K, Borghans JAM, Knol MJ, van Baarle D. Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis. Med Microbiol Immunol 2019;208:305-21. [PMID: 30949763 DOI: 10.1007/s00430-019-00602-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
47 Mcelhaney JE, Frasca D. Influenza Vaccination in Older Adults. Encyclopedia of Gerontology and Population Aging 2019. [DOI: 10.1007/978-3-319-69892-2_69-1] [Reference Citation Analysis]
48 Schaffner W, van Buynder P, McNeil S, Osterhaus ADME. Seasonal influenza immunisation: Strategies for older adults. Int J Clin Pract 2018;72:e13249. [PMID: 30216647 DOI: 10.1111/ijcp.13249] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
49 Kallemeijn MJ, Kavelaars FG, van der Klift MY, Wolvers-Tettero ILM, Valk PJM, van Dongen JJM, Langerak AW. Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging. Front Immunol 2018;9:448. [PMID: 29559980 DOI: 10.3389/fimmu.2018.00448] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
50 Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA, Witkowski JM, Franceschi C. Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? Front Immunol 2017;8:1960. [PMID: 29375577 DOI: 10.3389/fimmu.2017.01960] [Cited by in Crossref: 574] [Cited by in F6Publishing: 607] [Article Influence: 143.5] [Reference Citation Analysis]
51 Pallikkuth S, de Armas L, Rinaldi S, Pahwa S. T Follicular Helper Cells and B Cell Dysfunction in Aging and HIV-1 Infection. Front Immunol 2017;8:1380. [PMID: 29109730 DOI: 10.3389/fimmu.2017.01380] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
52 McElhaney JE, Andrew MK, McNeil SA. Estimating influenza vaccine effectiveness: Evolution of methods to better understand effects of confounding in older adults. Vaccine 2017;35:6269-74. [PMID: 29032898 DOI: 10.1016/j.vaccine.2017.09.084] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]